
IndraLab
Statements
reach
"The IC for hERG block by sotalol were measured by fitting the data to Hill’s equation as follows:
f(D)=11+(D/IC50)h
where f(D) is the current ratio in the presence of the drug at a given concentration (D) and h is the Hill coefficient.The data and datasets generated and analyzed in the current study can be accessed upon request sent to the corresponding author of the manuscript.3."
reach
"Thus, we concluded that human iPSC-CMs can recapitulate cardiotoxicity and identify the effects of well-characterized compounds.Previous studies have demonstrated that sotalol, chlorpromazine, and mexiletine inhibit hERG currents, which may explain the cardiac toxicity of these drugs [14-16]."
eidos
"This study investigated hERG block by cisapride , dofetilide , terfenadine , sotalol , and E-4031 - positive controls commonly used to demonstrate assay sensitivity - using the manual whole cell patch clamp method and an action potential-like voltage protocol presented at 0.2 Hz ."
reach
"As expected, hERG channel inhibitors such as sotalol, dofetilide, quinidine, and ranolazine caused a dose-related FPD prolongation independently from their classifications, confirming findings reported in previous studies (Blinova et al., 2017; Kanda et al., 2018; Millard et al., 2018)."
eidos
"How to resolve disconnect between clinical and experimental data One of the longstanding conundrums related to hERG block by sotalol is that relatively high concentration of drug required to block the channel when assessed in isolated cloned channels expressed in vitro compared to the relatively low plasma concentrations reported in humans that apparently result in substantial QT interval prolongation [ 34,82,115 ] ."
reach
"The N588K mutation has been shown to significantly attenuate sotalol induced blockade of hERG channels, while attenuating that of quinidine to a lesser extent.This is concordant with previous data showing that the molecular determinants of hERG blockade for some low affinity blockers (e.g., [89]) may differ from those associated with class III antiarrhythmic agents [45,50]."